Summary
Dr. Reddy's CDMO arm, Aurigene, has secured a long-term manufacturing agreement with a major global pharmaceutical company. This initial portfolio includes over 20 products, such as sterile injectables, biologics, and topical formulations, to be produced at Aurigene's Indian facilities.